V13K [F9f, A12a, V16v]

General Information


DRACP ID  DRACP03678

Peptide Name   V13K [F9f, A12a, V16v]

Sequence  KWKSFLKTfKSaKKTvLHTALKAISS

Sequence Length  26

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation

C-terminal Modification  Amidation

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C122H201N33O28

Absent amino acids  CDEGMNPQRVY

Common amino acids  K

Mass  302423

Pl  11.58

Basic residues  8

Acidic residues  0

Hydrophobic residues  8

Net charge  8

Boman Index  -3621

Hydrophobicity  -55.38

Aliphatic Index  67.69

Half Life 
  /

Extinction Coefficient cystines  5500

Absorbance 280nm  220

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29280948

Title  Enantiomeric Effect of d-Amino Acid Substitution on the Mechanism of Action of ?-Helical Membrane-Active Peptides

Doi Not available

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  10941

DRACP is developed by Dr.Zheng's team.